Tissue-specificity of insulin action and resistance*

References

• Araki E, Lipes MA, Patti ME, Brüning JC, Haag III BL, Johnson RS, Kahn CR. (1994). Alternative pathway of insulin signalling in mice made with targeted disruption of the IRS-1 gene. Nature 372:186–90.
   PubMed Web of Science ®Google Scholar
• Arribas M, Valverde AM, Benito M. (2003). Role of IRS-3 in the insulin signalling of IRS-1-deficient brown adipocytes. J Biol Chem 278:45189–99.
   PubMed Web of Science ®Google Scholar
• Arribas M, Valverde AM, Burks D, Klein J, Farese RV, White MF, Benito M. (2003). Essential role of protein kinase C ζ in the impairment of insulin-induced glucose transport in IRS-2-deficient brown adipocytes. FEBS Lett 536:161–6.
   PubMed Web of Science ®Google Scholar
• Biddinger SB, Kahn CR. (2006). From mice to men: Insights into the insulin resistance syndromes. Annu Rev Physiol 68:123–58.
   PubMed Web of Science ®Google Scholar
• Bjornholm M, He AR, Attersand A, Lake S, Liu SC, Lienhard GE, Taylor S, Arner P, Zierath JR. (2002). Absence of functional insulin receptor substrate-3 (IRS-3) gene in humans. Diabetologia 45:1697–702.
   PubMed Web of Science ®Google Scholar
• Bluher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, Kahn CR. (2002). Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3:25–38.
   PubMed Web of Science ®Google Scholar
• Bonner-Weir S. (2000). Life and death of the pancreatic β-cells. Trends Endocrinol Metab 11:375–8.
   PubMed Web of Science ®Google Scholar
• Briaud I, Lingohr MK, Dickson LM, Wrede CE, Rhodes CJ. (2003). Differential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic β-cells. Diabetes 52:974–83.
   PubMed Web of Science ®Google Scholar
• Bruning JC, Michael MD, Winna JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR. (1998). A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559–69.
   PubMed Web of Science ®Google Scholar
• Cline GW, Johnson K, Regitting W, Perret P, Tozzo E, Xiao L, Damico C, Shulman GI. (2002). Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 51:2903–10.
   PubMed Web of Science ®Google Scholar
• Cousin SP, Hugl SR, Myers, MG Jr, White MF, Reifel-Miller A, Rhodes CJ. (1999). Stimulation of pancreatic β-cell proliferation by growth hormone is glucose-dependent: signal transduction via Janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated. Biochem J 344, 649–58.
   PubMed Web of Science ®Google Scholar
• Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, et al. (2009). Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360:1509–17.
   PubMed Web of Science ®Google Scholar
• Desbois-Mouthon C, Danan C, Amselem S, Blivet-Van Eggelpoel MJ, Sert-Langeron C, Goosens M, Besmond C, Capeau J, Caron M. (1996). Severe resistance to insulin and insulin-like growth factor-I in cells from a patient with leprechaunism as a result of two mutations in the tyrosine kinase domain of the insulin receptor. Metabolism 45:1493–500.
   PubMed Web of Science ®Google Scholar
• Dor Y, Brown J, Martinez OI, Melton DA. (2004). Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41–6.
   PubMed Web of Science ®Google Scholar
• Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, et al. (1998). Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544–8.
   Web of Science ®Google Scholar
• Escribano O, Arribas M, Valverde AM, Benito M. (2007). IRS-3 mediates insulin-induced glucose uptake in differentiated IRS-2-/- brown adipocytes. Mol Cell Endocrinol 268:1–9.
   PubMed Web of Science ®Google Scholar
• Escribano O, Guillén C, Nevado C, Gómez-Hernández A, Kahn CR, Benito M. (2009). Beta-cell hyperplasia induced by hepatic insulin resistance: role of a liver-pancreatic endocrine axis through insulin receptor a isoform. Diabetes 58:820–28.
   PubMed Web of Science ®Google Scholar
• Fasshauer M, Klein J, Kriauciunas KM, Ueki K, Benito M, Kahn CR. (2001). Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Mol Cell Biol 21:319–29.
   PubMed Web of Science ®Google Scholar
• Ferre T, Riu E, Bosch F, Valera A. (1996). Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver. FASEB J 10:1213–18.
   Google Scholar
• Goldstein BJ, Ahmad F, Ding W, Li PM, Zhang WR. (1998). Regulation of the insulin signalling pathways by cellular protein-tyrosine phosphatases. Mol Cell Biochem 182:91–9.
   PubMed Web of Science ®Google Scholar
• Goldstein BJ, Bittner-Kowalczyk A, White MF, Harbeck M. (2000). Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb-2 adaptor molecule. J Biol Chem 11:4283–9.
   Google Scholar
• González-Rodriguez A, Clampit J, Escribano O, Benito M, Rondinone C, Valverde AM. (2007). Developmental switch from prolonged insulin action to increased sensitivity in PTP1B-deficient hepatocytes. Endocrinology 148:594–608.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Rodriguez A, Nevado C, Escrivá F, Sesti G, Rondinone C, Benito M, Valverde AM. (2008). PTP1B deficiency increases glucose uptake in neonatal hepatocytes: involvement of IRA/GLUT2 complexes. Am J Physiol Gastrointest Liver Physiol 295:338–47.
   PubMed Web of Science ®Google Scholar
• Guerra C, Navarro P, Valverde AM, Arribas M, Bruning J, Kozak LP, Kahn CR, Benito M. (2001). Brown adipose tissue specific insulin receptor knockout shows diabetic phenotype without insulin resistance. J Clin Invest 108:1205–13.
   PubMed Web of Science ®Google Scholar
• Guillen C, Bartolomé A, Nevado C, Benito M. (2008). Insulin induces apoptosis at long term in pancreatic beta cells. FEBS Letters 582:3855–60.
   PubMedGoogle Scholar
• Guillén C, Navarro P, Robledo M, Valverde AM, Benito M. (2006). Differential mitogenic signalling in insulin receptor-deficient foetal pancreatic β-Cells. Endocrinology 147:1959–68.
   PubMed Web of Science ®Google Scholar
• Hugl SR, White MF, Rhodes CJ. (1998). Insulin-like growth factor I (IGF-I) stimulated pancreatic β-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells. J Biol Chem 273:17771–9.
   PubMed Web of Science ®Google Scholar
• Kadowaki T. (2000). Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest 106:459–65.
   PubMed Web of Science ®Google Scholar
• Kahn CR. (1995). Diabetes. Causes of insulin resistance. Nature 373:384–5.
   PubMed Web of Science ®Google Scholar
• Kahn CR, Bruning JC, Michael MD, Kulkarni RN. (2000). Knockout mice challenge our concepts of glucose homeostasis and the pathogeneis of diabetes mellitus. J Pediatric Endocrinol Metab 13:1377–84.
   PubMed Web of Science ®Google Scholar
• Kitamura T, Kahn CR, Accili D. (2003). Insulin receptor knockout mice. Annu Rev Physiol 65:313–32.
   PubMed Web of Science ®Google Scholar
• Kitamura T, Nakae J, Kitamura I, Kido Y, Biggs WH, Wright CV, White MF, Arden KC, Accili D. (2002). The forkhead transcrition factor Foxo1 links insulin signalling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 110:1839–47.
   PubMed Web of Science ®Google Scholar
• Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, et al. (2000). Increased energy expenditure, decreased adiposity and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479–89.
   Google Scholar
• Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H, et al. (2000). Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49:1880–89.
   PubMed Web of Science ®Google Scholar
• Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. (1999). Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329–39.
   PubMed Web of Science ®Google Scholar
• Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, Kahn CR. (2002). β-cell-specific deletion of the IGF-1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass. Nat Genetics 31:111–15.
   PubMed Web of Science ®Google Scholar
• Kulkarni RN, Jhala US, Winnay J, Krajewski S, Montmini M, Kahn CR. (2004). PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest 114:828–36.
   PubMed Web of Science ®Google Scholar
• Kushner JA, Ye J, Schubert M, Burks DJ, Dow MA, Flint CL, Dutta S, Wright CV, Montmini MR, White MF. (2000). Pdx1 restores beta cell function in Irs2 knockout mice. J Clin Invest 109:1193–201.
   Web of Science ®Google Scholar
• Lavan BE, Lane WS, Lienhard GE. (1997). The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 272, 11439–43.
   PubMed Web of Science ®Google Scholar
• Lee YH, White MF. (2004). Insulin receptor substrate proteins and diabetes. Arch Phar Res 27:361–70.
   PubMed Web of Science ®Google Scholar
• LeRoith D, Gavrilova O. (2006). Mouse models created to study the pathophysiology of Type 2 diabetes. Int J Biochem Cell Biol 38:904–12.
   PubMed Web of Science ®Google Scholar
• Michael MD, Kulkarni RN, Postic C, Previs SF, Schulman GI, Magnuson MA, Kahn CR. (2000). Loss of insulin signalling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87–97.
   PubMed Web of Science ®Google Scholar
• Nakae J, Biggs III WH, Kitamura T, Cavenee WK, Wright CE, Arden KC, Accili D. (2002). Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genetics 32:245–53.
   PubMed Web of Science ®Google Scholar
• Nakae J, Kitamura T, Silver DL, Accili D. (2001). The forkhead transcription factor foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108:1359–67.
   PubMed Web of Science ®Google Scholar
• Nandi A, Kitamura Y, Kahn CR, Accili D. (2003). Mouse models of insulin resistance. Physiol Rev 84:623–47.
   Google Scholar
• Okada T, Liew CW, Hu J, Hinault C, Michael MD, Krutzfeld J, Yin C, Holzember M, Stoffel M, Kulkarni RN. (2007). Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci USA 104:8977–982.
   PubMed Web of Science ®Google Scholar
• Otani K, Kulkarni RN, Baldwin AC, Krutzfeldt J, Ueki K, Stoffel M, Kahn RC, Polonski KS. (2004). Reduced β-cell mass and altered glucose sensing impair insulin-secretory function in BIRKO mice. Am J Physiol Endocrinol Metab 286:41–9.
   PubMed Web of Science ®Google Scholar
• Previs SF, Withers DJ, Ren JM, White MF, Shulman GI. (2000). Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J Biol Chem 275:38990–94.
   PubMed Web of Science ®Google Scholar
• Rhodes CJ. (2000). IGF-I and GH post-receptor signalling mechanisms for pancreatic β-cell replication. J Mol Endocrinol 24:303–11.
   PubMed Web of Science ®Google Scholar
• Roth RA. 1994. Biochemical mechanisms of insulin resistance. Horm Res 41:51–5.
   PubMed Web of Science ®Google Scholar
• Seely BL, Staubs PA, Reichart DR, Berhanu P, Milarski KL, Saltiel AR, Kusari J, Olefsky JM. (1996). Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes 45:1379–85.
   PubMed Web of Science ®Google Scholar
• Smith FE, Rosen KM, Villa-Komaroff J, Weir GC, Bonner-Weir S. (1991). Enhanced insulin-like growth factor I gene expression in regenerating rat pancreas. Proc Natl Acad Sci USA 88:6152–6.
   PubMed Web of Science ®Google Scholar
• Somwar R, Sumitani S, Taha C, Sweene G, Klip A. (1998). Temporal activation of p70S6 kinase and akt1 by insulin: PI 3-kinase-dependent and -independent mechanisms. Am J Physiol 4:618–25.
   Google Scholar
• Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MG, Glashee E, Lane WS, Pierce JH, White MF. (1995). Role of IRS-2 in insulin and cytokine signalling. Nature 773:173–7.
   Google Scholar
• Swenne I. (1992). Pancreatic β-cell growth and diabetes mellitus. Diabetologia 35:193–201.
   PubMed Web of Science ®Google Scholar
• Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Yaburagi Y, Satoh S, et al. (1994). Insulin resistance and growth retardation in mice made with targeted disruption of the IRS-1 gene. Nature 372:182–6.
   PubMed Web of Science ®Google Scholar
• Tobe K, Tamemoto H, Yamaushi T, Aizawa S, Yazaki Y, Kadowaki T. (1995). Identification of a 190-Kda protein as a novel substrate for the insulin receptor kinase functionally similar to insulin receptor substrate-1. J Biol Chem 270:5698–701.
   PubMed Web of Science ®Google Scholar
• Trinh KY, O’Doherty RM, Anderson P, Lange AJ, Newgard C.B. (1998). Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J Biol Chem 273:31615–20.
   PubMed Web of Science ®Google Scholar
• Tseng YH, Kriaciunas KM, Kokkotou E, Kahn CR. (2004). Differential roles of insulin receptor substrates in brown adipocyte differentiation. Mol Cell Biol 24, 1918–29.
   PubMed Web of Science ®Google Scholar
• Valera A, Pujol A, Pelegrin M, Bosch F. (1994). Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91:9151–4.
   Google Scholar
• Valverde AM, Arribas M, Mur C, Navarro P, Pons S, Cassard-Doulcier AM, Kahn CR, Benito M. (2003). Insulin-induced UCP-1 expression is mediated by IRS-1 through phosphatidylinositol 3-kinase/Akt signalling pathway in foetal brown adipocytes. J Biol Chem 278:10221–31.
   PubMed Web of Science ®Google Scholar
• Valverde AM, Burks D, Fabregat I, Fisher T, Carretero J, White MF, Benito M. (2003). Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes. Diabetes 52, 2239–48.
   PubMed Web of Science ®Google Scholar
• Valverde AM, Kahn CR, Benito M. (1999). Insulin signalling in insulin receptor substrate (IRS)-1-deficient brown adipocytes: requirement of IRS-1 for lipid synthesis. Diabetes 48, 2122–31.
   PubMed Web of Science ®Google Scholar
• Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF. (1999). IRS-2 coordinates IGF-I receptor-mediated β-cell development and peripheral insulin signalling. Nat Genetics 23:32–40.
   PubMed Web of Science ®Google Scholar
• Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, et al. (1998). Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–904.
   PubMed Web of Science ®Google Scholar
• Xiaocheng C, Kyle D, Copps D, Guo S, Li Y, Kollipara R, DePinho RA, White MF. (2008). Inactivation of hepatic foxo1 by insulin signalling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metabolism 8, 65–76.
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Tobe K, Tamemoto H, Ueki K, Kaburagi Y, Yamamoto-Honda R, Takahashi Y, Yoshizawa F, Aizawa S, Akanuma Y, et al. (1996). Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate-1-deficient mice. Mol Cell Biol 16:3074–84.
   PubMed Web of Science ®Google Scholar